• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Option Care Health Inc. (Amendment)

    2/13/24 5:12:03 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care
    Get the next $OPCH alert in real time by email
    SC 13G/A 1 tv01622-optioncarehealthinc.htm SCHEDULE 13G/A optioncarehealthinc

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 3)*

    Name of issuer:  Option Care Health Inc

    Title of Class of Securities:  Common Stock

    CUSIP Number:  68404L201

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  68404L201

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    310,154

    7.  SOLE DISPOSITIVE POWER

    19,129,873

    8.  SHARED DISPOSITIVE POWER

    496,332

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    19,626,205

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    11.08%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Option Care Health Inc

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    3000 Lakeside Drive, Suite 300N
    Bannockburn, IL 60015

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    68404L201

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $OPCH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OPCH

    DatePrice TargetRatingAnalyst
    4/30/2025$40.00Neutral → Buy
    UBS
    1/23/2025$26.00 → $35.00Hold → Buy
    Jefferies
    1/13/2025$26.00 → $33.00Neutral → Buy
    BofA Securities
    12/5/2024$26.00Neutral
    UBS
    11/4/2024$27.00Buy → Neutral
    Goldman
    10/31/2024$38.00 → $26.00Buy → Hold
    Jefferies
    10/30/2024$43.00 → $29.00Buy → Neutral
    BofA Securities
    7/16/2024$36.00Mkt Outperform
    JMP Securities
    More analyst ratings

    $OPCH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Option Care Health to Participate in Upcoming Investor Conferences

      BANNOCKBURN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The Bank of America Healthcare Conference, being held in Las Vegas, on Tuesday, May 13, 2025, including a presentation at 8:00am PT/11:00am ET.The William Blair 45th Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 3, 2025, including a presentation at 11:20am CT/12:20pm ET.The Goldman Sachs 46th Annual Global Healthcare Conference, being held in Miami, on Monday, June 9, 2025, including a fireside chat

      5/1/25 4:05:00 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2025

      BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenue of $1,333.0 million, up 16.3% compared to $1,146.1 million in the first quarter of 2024Gross profit of $263.1 million, or 19.7% of net revenue, up 10.3% compared to $238.5 million, or 20.8% of net revenue, in the first quarter of 2024Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted

      4/29/25 7:00:00 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health to Announce First Quarter 2025 Financial Results and Host Conference Call

      BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI29e3b2a044544585b1ab833b09a90572. The call can also be accessed via a liv

      3/24/25 4:05:00 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care